197 related articles for article (PubMed ID: 25394108)
1. Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa.
Simmons B; Hill A; Ford N; Ruxrungtham K; Ananworanich J
J Int AIDS Soc; 2014; 17(4 Suppl 3):19604. PubMed ID: 25394108
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
3. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
Chien CV
PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
[TBL] [Abstract][Full Text] [Related]
4. Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018.
Hill A; Hill T; Jose S; Pozniak A
J Int AIDS Soc; 2014; 17(4 Suppl 3):19497. PubMed ID: 25394006
[TBL] [Abstract][Full Text] [Related]
5. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.
Lee JSF; Sagaon Teyssier L; Dongmo Nguimfack B; Collins IJ; Lallemant M; Perriens J; Moatti JP
BMC Pediatr; 2016 Mar; 16():41. PubMed ID: 26979974
[TBL] [Abstract][Full Text] [Related]
6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
7. Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community.
Liu Y; Galárraga O
Health Policy Plan; 2017 Mar; 32(2):170-177. PubMed ID: 28207060
[TBL] [Abstract][Full Text] [Related]
8. Is pricing of dolutegravir equitable? A comparative analysis of price and country income level in 52 countries.
Sim J; Hill A
J Virus Erad; 2018 Oct; 4(4):230-237. PubMed ID: 30515303
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
; Slogrove AL; Schomaker M; Davies MA; Williams P; Balkan S; Ben-Farhat J; Calles N; Chokephaibulkit K; Duff C; Eboua TF; Kekitiinwa-Rukyalekere A; Maxwell N; Pinto J; Seage G; Teasdale CA; Wanless S; Warszawski J; Wools-Kaloustian K; Yotebieng M; Timmerman V; Collins IJ; Goodall R; Smith C; Patel K; Paul M; Gibb D; Vreeman R; Abrams EJ; Hazra R; Van Dyke R; Bekker LG; Mofenson L; Vicari M; Essajee S; Penazzato M; Anabwani G; Q Mohapi E; N Kazembe P; Hlatshwayo M; Lumumba M; Goetghebuer T; Thorne C; Galli L; van Rossum A; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaia L; Rojo P; Fortuny C; Naver L; Rudin C; Le Coeur S; Volokha A; Rouzier V; Succi R; Sohn A; Kariminia A; Edmonds A; Lelo P; Ayaya S; Ongwen P; Jefferys LF; Phiri S; Mubiana-Mbewe M; Sawry S; Renner L; Sylla M; Abzug MJ; Levin M; Oleske J; Chernoff M; Traite S; Purswani M; Chadwick EG; Judd A; Leroy V
PLoS Med; 2018 Mar; 15(3):e1002514. PubMed ID: 29494593
[TBL] [Abstract][Full Text] [Related]
10. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
11. The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund.
Vasan A; Hoos D; Mukherjee JS; Farmer PE; Rosenfield AG; Perriëns JH
Bull World Health Organ; 2006 May; 84(5):393-8. PubMed ID: 16710550
[TBL] [Abstract][Full Text] [Related]
12. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study.
Estill J; Ford N; Salazar-Vizcaya L; Haas AD; Blaser N; Habiyambere V; Keiser O
Lancet HIV; 2016 Mar; 3(3):e132-9. PubMed ID: 26939736
[TBL] [Abstract][Full Text] [Related]
13. Examining the production costs of antiretroviral drugs.
Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
[TBL] [Abstract][Full Text] [Related]
14. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.
Wirtz VJ; Santa-Ana-Tellez Y; Trout CH; Kaplan WA
Health Policy Plan; 2012 Dec; 27(8):638-48. PubMed ID: 22367770
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to healthcare access for children with disabilities in low and middle income sub-Saharan African countries: a scoping review.
Adugna MB; Nabbouh F; Shehata S; Ghahari S
BMC Health Serv Res; 2020 Jan; 20(1):15. PubMed ID: 31906927
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement.
Danzon PM; Mulcahy AW; Towse AK
Health Econ; 2015 Feb; 24(2):238-52. PubMed ID: 24293058
[TBL] [Abstract][Full Text] [Related]
17. The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
Schneider K; Nwizu C; Kaplan R; Anderson J; Wilson DP; Emery S; Cooper DA; Boyd MA
PLoS One; 2013; 8(2):e54435. PubMed ID: 23457450
[TBL] [Abstract][Full Text] [Related]
18. Cigarette prices in eight sub-Saharan African countries in 2018: a cross-sectional analysis.
Chang K; Mayne E; Laverty AA; Agaku I; Filippidis FT
BMJ Open; 2021 Oct; 11(10):e053114. PubMed ID: 34620669
[TBL] [Abstract][Full Text] [Related]
19. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
20. The impact of African-trained neurosurgeons on sub-Saharan Africa.
Karekezi C; El Khamlichi A; El Ouahabi A; El Abbadi N; Ahokpossi SA; Ahanogbe KMH; Berete I; Bouya SM; Coulibaly O; Dao I; Djoubairou BO; Doleagbenou AAK; Egu KP; Ekouele Mbaki HB; Kinata-Bambino SB; Habibou LM; Mousse AN; Ngamasata T; Ntalaja J; Onen J; Quenum K; Seylan D; Sogoba Y; Servadei F; Germano IM
Neurosurg Focus; 2020 Mar; 48(3):E4. PubMed ID: 32114560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
